Analysis summary
MRNA screens neutral with a 7/100 direction score. Bullish evidence includes Monte Carlo mean projected close is above current spot; Risk reversal is call-heavy at 0.0552. Bearish evidence includes AI prediction leans down at 40.8% probability up; Max Pain sits below spot, suggesting downward expiry pin pressure.